brain death exams
- related: ICU intensive care unit
- tags: #icu
Brain Death
Links to this note
When clinical criteria suggest brain death, the best next step is apnea testing. Patients must be hemodynamically stable with a body temperature > 36 C (97 F), normal pH, and normal PaCO2/PaO2 levels. Apnea testing objectively confirms brainstem failure if the patient cannot generate spontaneous breaths or trigger the ventilator in response to elevated PaCO2 levels > 10 minutes after disabling control mode (Choice E).
Patients are first pre-oxygenated with 100% oxygen for 10 minutes using existing ventilatory support, and then mechanical ventilation is discontinued. However, they should continue to passively receive 100% oxygen while the chest and abdomen are observed for spontaneous respirations for approximately 10 minutes. If spontaneous respirations are observed, the apnea test is negative and the patient is not brain dead. A positive test is defined as no spontaneous respirations and requires another clinical brain death examination for confirmation. In addition, repeat ABG must confirm that the PaCO2 was > 60 mm Hg or that it increased > 20 mm Hg from the baseline ABG. Patients who cannot tolerate apnea testing or have inconclusive results require ancillary diagnostic tests to confirm brain death.
(Choice A) The atropine response test involves administering atropine and observing for an increase in heart rate (> 3%). Although the vagal nucleus in the medulla may be one of the last functions lost in brain death, the atropine response test provides a limited assessment and has not been well validated for confirming brain death.
(Choice C) Cerebral blood flow testing (e.g., cerebral angiogram or cerebral scintigraphy) is the gold standard test for brain death confirmation, but it is highly invasive and not used routinely as the initial step for diagnosing brain death. Cerebral blood flow testing may be used in patients with an unreliable clinical examination or bedside apnea test.
(Choice D) Current guidelines do not recommend EEG with ECI protocol for brain death confirmation, as it is susceptible to excessive artifact from other electrical devices in the ICU that make it less reliable. In addition, EEG is very sensitive to the effects of sedative medications and metabolic derangements, and therefore can be easily confounded by those variables.
This patient has a high likelihood of having evolved to irreversible cessation of brain function. Determination of brain death includes apnea testing, defined as a failure of the medulla to drive respiratory efforts despite an elevation of the PaCO2 to 60 or 20 mm Hg higher than a known elevated baseline (choice A is correct).
The need for determination of brain death by means of clinical assessment arises as a result of the growing frequency in the use of life support in the modern hospital over the past 70 years. After determination that either a direct (eg, stroke, trauma) or indirect (eg, hypoxia, cardiac arrest) insult has caused irreversible cessation of all functions of the entire brain, including the brainstem, death can be declared, with a legal basis for this determination provided in the United States by the Uniform Determination of Death Act. This process accounts for approximately 2% of hospital deaths (choice B is incorrect).
General principles that guide this determination include beginning with identification of the mechanism of brain injury and exclusion of conditions that suppress neurologic function and potentially confound determination of brain death such as hypothermia, shock, and drug overdose. In most jurisdictions, well-documented, thorough, bedside neurologic examinations can by themselves be used to diagnose brain death, although in ambiguous circumstances or when the neurologic examination is necessarily limited, ancillary testing, including imaging; EEG; and, most importantly, blood flow measurement, are used. In cases of global anoxic injury, such as that after cardiac arrest, it is generally recommended that two examinations 24 h apart be conducted; nonetheless, study results have shown that return of neurologic function at the time of the second examination is not seen after proper testing in many patients (choice D is incorrect).
The neurologic examination for determination of brain death begins by confirmation of coma by nonresponsiveness to auditory, visual, or tactile stimuli. Testing for tactile pain should include stimulation not only of arms, legs, and trunk but also of the supraorbital notch and the temporomandibular joint because high cord lesions or peripheral neuropathies may confound a more limited examination (choice C is incorrect). Testing for brainstem reflexes includes pupillary, corneal, oculocephalic, oculovestibular, gag, and cough reflexes, which all must be absent. This testing is essential to avoid interpreting high cord or low brainstem lesions producing a locked-in syndrome as true brain death.
If these indicate no cortical or brainstem function, apnea testing is conducted. The absence of respiratory effort in response to hypercarbia and acidosis is consistent with brain death. The risk of this procedure is cardiovascular collapse caused by hypoxia. Accordingly, cardiovascular stability should be established before testing is attempted, and preoxygenation to PaO2 higher than 200 mm Hg is desirable. At this point, the patient is removed from mechanical ventilation, and apneic oxygenation is provided through a tracheal catheter with an oxygen flow rate of 4 to 6 L/min. For at least 10 min, the patient is observed for respiratory efforts, the presence of which would exclude brain death. Arterial blood gases are followed, and when the PCO2 exceeds 60 mm Hg or climbs by more than 20 mm Hg in a patient with chronic CO2 retention, the test is interpreted as consistent with brain death. In cases in which severe hypoxemic respiratory failure has occurred and the patient is PEEP dependent to avoid severe hypoxemia, there may not be adequate time off the ventilator to secure a diagnosis of brain death through apnea testing.1